Aspadol 150 mg (Tapentadol) – Long‑Lasting Relief for Severe Pain

Aspadol 150 mg is a prescription opioid pain reliever containing tapentadol hydrochloride, formulated as an extended‑release tablet. It is used for the treatment of moderate to severe acute and chronic pain, including post‑surgical pain, musculoskeletal pain, and neuropathic pain. Each Aspadol 150 mg tablet provides up to 12 hours of continuous pain relief when taken as directed by a licensed healthcare provider.

How Aspadol 150 mg (Tapentadol) Works

Aspadol 150 mg contains tapentadol, a centrally‑acting synthetic analgesic known for its dual mechanism of action. It acts as a μ‑opioid receptor agonist, which reduces pain signals in the central nervous system, and simultaneously inhibits the reuptake of norepinephrine, enhancing descending pain‑inhibiting pathways in the spinal cord.

Because of this dual action, Aspadol 150 mg delivers strong pain relief with a potentially lower incidence of severe gastrointestinal side effects—such as nausea and constipation—compared with some traditional opioids, especially when used in extended‑release form.

Uses of Aspadol 150 mg (Tapentadol)

Aspadol 150 mg (tapentadol extended release) is indicated for the management of:

• Moderate to severe chronic pain that requires long‑term opioid therapy
• Severe acute pain after surgery or major injury
• Neuropathic pain or musculoskeletal pain when other non‑opioid treatments are not providing adequate relief

Doctors generally prescribe Aspadol 150 mg when around‑the‑clock (24‑hour), continuous pain control is needed and other options such as non‑steroidal anti‑inflammatory drugs (NSAIDs) or milder opioids are insufficient.

Dosage & How to Use Aspadol 150 mg

Important: Aspadol 150 mg is a prescription opioid and must be used only under medical supervision. Individualized titration based on pain level, tolerability, and prior opioid use is essential.

Standard adult dosage (tapentadol 150 mg ER):

• Usual dose: 100–250 mg every 12 hours (morning and evening).
• Maximum daily dose: up to 500 mg per day (250 mg x 2 doses).
• For patients switching from immediate‑release tapentadol, doctors convert the total daily IR dose to an equivalent ER dose, typically divided into two 12‑hour doses.

Instructions for use:

• Swallow Aspadol 150 mg whole; do not crush, chew, or break the tablet, as this can cause rapid release of the opioid and risk of overdose.
• Take with or without food as directed; taking with food may reduce nausea in some patients.
• Do not increase the dose, shorten the dosing intervals, or take more tablets than prescribed without explicit medical advice.
• If a dose is missed, take it as soon as possible unless it is close to the next scheduled dose; do not double‑dose.

Safety Guidelines for Aspadol 150 mg

Aspadol 150 mg (tapentadol) is a controlled opioid medication and carries a black‑box warning regarding addiction, abuse, misuse, and the risk of life‑threatening respiratory depression.

Important safety points:

• Not for use in patients with significant respiratory depression, severe or uncontrolled asthma, or paralytic ileus.
• Use with caution in patients with liver disease, kidney impairment, or a history of substance use disorder.
• Concomitant use with other central nervous system (CNS) depressants such as alcohol, benzodiazepines, or sedatives can increase the risk of slow breathing, extreme drowsiness, coma, or death.
• Not recommended during pregnancy or breastfeeding without medical supervision, due to risks of neonatal withdrawal syndrome and fetal harm.
• Never share Aspadol 150 mg with another person, even if they have similar symptoms. Accidental ingestion by children or opioid‑naïve adults can be fatal.
• Gradual tapering is required to stop after long‑term use to prevent withdrawal symptoms.

Seek emergency medical help if you experience slow or shallow breathing, pinpoint pupils, extreme drowsiness, inability to wake up, or signs of allergic reaction (swelling, rash, difficulty breathing).

Side Effects of Aspadol 150 mg (Tapentadol)

Most patients tolerate tapentadol reasonably well, especially at the 150 mg extended‑release dose. The most common side effects of Aspadol 150 mg include:

• Nausea, vomiting, or stomach discomfort
• Constipation or dry mouth
• Dizziness, drowsiness, or fatigue
• Headache, sweating, or flushing

These side effects are often mild and may improve over time. If they persist, worsen, or become disruptive, consult your doctor. Serious side effects requiring immediate medical attention include:

• Slow or irregular breathing, shortness of breath, or chest pain
• Fainting, confusion, unusual drowsiness, or inability to stay awake
• Severe dizziness or feeling like you may pass out
• Signs of serotonin syndrome (agitation, hallucinations, high fever, fast heartbeat, muscle stiffness, tremors, loss of coordination)
• Severe allergic reactions (hives, swelling of face or throat, wheezing, difficulty breathing)

Drug Interactions with Aspadol 150 mg

Aspadol 150 mg (tapentadol) can interact with many medications, increasing the risk of side effects or serious complications:

• Other opioids, benzodiazepines, alcohol, and sedative drugs (increased risk of respiratory depression and sedation)
• Antidepressants such as SSRIs and SNRIs, and MAO inhibitors (increased risk of serotonin syndrome)
• Antipsychotics, some antihistamines, muscle relaxants, and other CNS depressants
• Certain drugs that affect liver enzymes (CYP2D6, CYP3A4) may change how tapentadol works or increase toxicity.

Always inform your prescriber about all medications, supplements, and herbal products you are taking before starting Aspadol 150 mg.

Who Should Avoid Aspadol 150 mg (Tapentadol)?

Aspadol 150 mg may not be suitable or may require careful monitoring in the following groups:

• Patients with known opioid dependence, substance use disorder, or uncontrolled addiction history
• Those with severe respiratory conditions, such as severe COPD, uncontrolled asthma, or sleep apnea
• People with severe liver or kidney disease
• Patients who have recently taken or are taking MAO inhibitors (monoamine oxidase inhibitors)
• Individuals who cannot swallow whole tablets safely

Inform your doctor about your full medical history, including prior opioid use, heart, liver, or kidney problems, and mental health conditions, before starting this medication.

Storage, Handling & Disposal

Store Aspadol 150 mg at room temperature, away from moisture and heat. Keep the medication in its original packaging and in a locked, child‑proof location, out of reach of children and pets.

Properly dispose of unused or expired tablets through a pharmacy take‑back program or as advised by local regulations. Do not flush tapentadol down the toilet or throw it into household trash as loose tablets, as this can pose environmental and safety risks.

Medical Disclaimer

This information about Aspadol 150 mg (tapentadol) is provided for educational purposes only and does not replace medical advice from a licensed healthcare professional. Aspadol 150 mg is a prescription opioid medication and must be used only under medical supervision. Do not self‑diagnose, self‑prescribe, or alter your dose without consulting your doctor. Always follow the instructions on your prescription label and the package leaflet.